Clinical Trial Update: The Medacta Quadra-P Anteverted Study

View source ↗

Summary

Update on the Medacta Quadra-P Anteverted hip study; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avascular Necrosis of the Femoral Head
• Developmental Dysplasia of the Hip
• Osteoarthritis
• Rheumatoid Arthritis
• Traumatic Arthritis

Snippet

Sponsor: Medacta International SA | Conditions: Arthrosis, Traumatic Arthritis | Status: ACTIVE_NOT_RECRUITING